News & Events
On this page
ORDR Co-Sponsored Conferences
The Tenth International Catecholamine Symposium (XICS), Sunday, September 09, 2012 - Thursday, September 13, 2012
Location: Ailomar Conference Grounds, Pacific Grove, CA
Description: The Tenth International Catecholamine Symposium (XICS) will emphasize integration of basic science with clinical pathophysiology, by a program centering on disease-oriented research about catecholamine systems. The goals of the XICS are to: disseminate the latest important basic scientific, disease-oriented, and patient-oriented medical advances about catecholamines; foster interactions among basic scientists, disease-oriented researchers, and clinical investigators, via common interests in catecholamine systems; emphasize integrative approaches for understanding the roles of catecholamines in cellular, organ, systemic, and organismic integrity; comprehensively update research on catecholamines in rare and common disorders of development in pediatrics, regulation in adults, and degeneration in the elderly; and foster synthesis of molecular genetics with integrative physiology and pathophysiology, based on evolving understanding of catecholamine systems.
Overcoming Barriers to International Clinical Trials for Rare Cancers , Friday, December 10, 2010
Location: Bethesda, Maryland
Description: The goals of this conference were to introduce key institutional players to the topic of international clinical trials in rare cancers and to establish an ongoing dialogue. Participants left the meeting with a set of specific priorities that need to be enacted to promote these trials. The meeting promoted consensus on the way that resources are prioritized to address rare cancers. Participants were asked to convey the content of the meeting to their constituencies and to follow up with pilot concepts.
Translational Genomics of Neuroblastoma (TGiN) Year 3, Thursday, November 12, 2009 - Friday, November 13, 2009
Location: Building 31, NIH Bethesda, Bethesda, MD
Description: Goals of this conference were to (1) identify novel validated biomarkers for predicting prognosis, (2) identify and discuss novel targets, (3) update technology, (4) update collaborative models, (5) design a future collaborative study, (6) generate a database and release data, and (7) discuss and confirm the funding mechanisms.